logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Dongdong Zhou

shandong first medical university and shandong academy of medical sciences
H指数:13
被引数:570

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combined therapy with DR5-targeting antibody-drug conjugate and CDK inhibitors as a strategy for advanced colorectal cancer

联合使用靶向DR5的抗体偶联药物和CDK抑制剂作为治疗晚期结直肠癌的策略

Cell Reports Medicine
IF10.6
2025-05-300
OA
Dongdong Zhou; Er’jiang Tang; Wenjun Wang; Youban Xiao; Jianming Huang; Jie Liu; Chao Zheng; Kai Zhang; Ruxia Hu; Feiqi Wang; Peng Xiong; Xin Chu; Weisong Li; Dongqin Liu; Xiangfu Zeng; Dexian Zheng; Liefeng Wang; Yong Zheng; Shuyong Zhang
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial

既往接受过曲妥珠单抗辅助和/或新辅助治疗的患者中，吡托替尼联合白蛋白结合型紫杉醇一线治疗HER2-positive转移性乳腺癌的疗效和安全性: 单臂2期前瞻性临床试验的1期结果

CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2024-05-130
OAAI
Man, Xiaochu; Huang, Jie; Sun, Shujuan; Zhou, Dongdong; Zhang, Baoxuan; Fang, Shu; Zheng, Fangchao; Li, Chao; Wang, Xinzhao; Huang, Wei; Wang, Linlin; He, Qingqing; Fu, Hui; Zhang, Yan; Liu, Changrui; Dong, Lin; Zhao, Xianguang; Xu, Liang; Sun, Xiao; Fan, Bingjie; Song, Lihua; Zhou, Zhengbo; Yu, Jinming; Li, Huihui
Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Li, Huihui; Tan, Qiaorui; Sun, Shujuan; Zhou, Dongdong; Yu, Bo; Su, Mu; Li, Baojiang; Fang, Shu; Qiang, Ling; Ren, Guohua; Bu, Bing; Yin, Sha; Man, Xiaochu; Qiu, Pengfei; Wang, Xinzhao; Li, Chao; Cao, Fangli; Shao, Qian; Han, Dali; Song, Lihua; Fan, Bingjie; Zhang, Baoxuan; Xu, Liang; Zhao, Xianguang; Liao, Yuqian; Xie, Xuemei; Liu, Lanping

研究方向

暂未获取到该数据
T
Teng Pan
H 指数:18论文数:104被引数:1,065
S
Shuyong Zhang
H 指数:20论文数:114被引数:1,376
D
Dexian Zheng
H 指数:33论文数:152被引数:6,789
L
Lixia Cao
H 指数:11论文数:102被引数:718
Z
Zhendong Shi
H 指数:25论文数:78被引数:2,460
L
Liefeng Wang
H 指数:15论文数:30被引数:755
Y
Yanyan Xuan
H 指数:10论文数:22被引数:597
C
Chao Zheng
H 指数:17论文数:53被引数:1,564
B
Baoxuan Zhang
H 指数:8论文数:41被引数:314
S
Shaorong Zhao
H 指数:12论文数:44被引数:544